Evidence mapPaperPMID 36834895Full record

ReviewInternational journal of molecular sciences2023

The Role of Red Cell Distribution Width as a Prognostic Marker in Chronic Liver Disease: A Literature Review.

Hunain Aslam, Fouzia Oza, Khalid Ahmed, Jonathan Kopel, Mark M Aloysius, Aman Ali, Dushyant Singh Dahiya, Muhammad Aziz, Abhilash Perisetti, Hemant Goyal

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Hunain AslamThe Wright Center for Graduate Medical Education, 501 S. Washington Ave, Scranton, PA 18505, USA.ORCID 0000-0002-1234-1318
Fouzia OzaThe Wright Center for Graduate Medical Education, 501 S. Washington Ave, Scranton, PA 18505, USA.
Khalid AhmedDepartment of Medicine, The Wright Center for Graduate Medical Education, 501 S. Washington Ave, Scranton, PA 18505, USA.
Jonathan KopelDepartment of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.ORCID 0000-0001-5934-2695
Mark M AloysiusDepartment of Medicine, The Wright Center for Graduate Medical Education, 501 S. Washington Ave, Scranton, PA 18505, USA.ORCID 0000-0001-6191-0524
Aman AliDepartment of Medicine, The Wright Center for Graduate Medical Education, 501 S. Washington Ave, Scranton, PA 18505, USA.
Dushyant Singh DahiyaDepartment of Internal Medicine, Central Michigan University College of Medicine, Saginaw, MI 48603, USA.ORCID 0000-0002-8544-9039
Muhammad AzizDepartment of Gastroenterology and Hepatology, University of Toledo Medical Center, Toledo, OH 43614, USA.ORCID 0000-0001-5620-8597
Abhilash PerisettiDepartment of Gastroenterology and Hepatology, Kansas City VA Medical Center, Kansas City, KS 64128, USA.ORCID 0000-0003-4074-6395
Hemant GoyalCenter for Interventional Gastroenterology at UT (iGUT), Division of Gastroenterology, Hepatology, and Nutrition, The University of Texas Health Science Center, 6431 Fannin, MSB 4.234, Houston, TX 77030, USA.ORCID 0000-0002-9433-9042
The Wright Center for Graduate Medical Education · USCentral Michigan University · USKansas City VA Medical Center · USTexas Tech University · USThe University of Texas Health Science Center at Houston · USUniversity of Toledo Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver disease is one of the leading public health problems faced by healthcare practitioners regularly. As such, there has been a search for an inexpensive, readily available, non-invasive marker to aid in monitoring and prognosticating hepatic disorders. Recently, red blood cell distribution width (RDW) has been found to be associated with various inflammatory conditions with implications for its use as a potential marker for assessing disease progression and prognosis in multiple conditions. Multiple factors effect red blood cell production whereby a dysfunction in any process can lead to anisocytosis. Furthermore, a chronic inflammatory state leads to increased oxidative stress and produces inflammatory cytokines causing dysregulation and increased intracellular uptake and use of both iron and vitamin B12, which leads to a reduction in erythropoiesis causing an increase in RDW. This literature review reviews in-depth pathophysiology that may lead to an increase in RDW and its potential correlation with chronic liver diseases, including hepatitis B, hepatitis C, hepatitis E, non-alcoholic fatty liver disease, autoimmune hepatitis, primary biliary cirrhosis, and hepatocellular carcinoma. In our review, we examine the use of RDW as a prognostic and predictive marker for hepatic injury and chronic liver disease.

Indexed as

Carcinoma, HepatocellularHepatitis BLiver NeoplasmsErythrocyte IndicesHumansPrognosisautoimmune hepatitishepatocellular carcinomanon-alcoholic fatty liver diseaseprimary biliary cholangitisred cell distribution widthviral hepatitis

Identifiers

PMID36834895
PMCPMC9967940
OpenAlexW4319923577

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.